4179F Tamoxifen/ai prescribed
Also known as: hormonal breast cancer therapy measure, tamoxifen or AI prescription measure, breast cancer hormone therapy
Performance measure code indicating that tamoxifen or aromatase inhibitor was prescribed for breast cancer treatment or prevention.
In Plain Language
breast cancer hormone medication; tamoxifen or aromatase inhibitor given; breast cancer prevention medication
Clinical Context
Quality measure for breast cancer care tracking prescription of appropriate hormonal therapy including tamoxifen in premenopausal or aromatase inhibitors in postmenopausal women.
RVU Information
CPT 4179F does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Documentation should include the clinical indication, service details, and any applicable performance metrics. Coverage may vary by payer — verify acceptance before billing.
Specialties
Frequently Asked Questions
What is CPT code 4179F?
CPT 4179F (Tamoxifen/ai prescribed) is a Other code. Performance measure code indicating that tamoxifen or aromatase inhibitor was prescribed for breast cancer treatment or prevention.
Who uses CPT code 4179F?
CPT 4179F is used by Oncology, Surgical Oncology, Breast Surgery. Quality measure for breast cancer care tracking prescription of appropriate hormonal therapy including tamoxifen in premenopausal or aromatase inhibitors in postmenopausal women.
When is CPT 4179F used?
Quality measure for breast cancer care tracking prescription of appropriate hormonal therapy including tamoxifen in premenopausal or aromatase inhibitors in postmenopausal women.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.